Jacques Schipper

Title: Jacques Schipper: Innovator in CNS Disorder Treatment

Introduction

Jacques Schipper is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmacology, particularly in the development of compounds aimed at treating central nervous system (CNS) disorders. His innovative work has led to the creation of a unique patent that showcases his expertise and dedication to advancing medical science.

Latest Patents

One of Jacques Schipper's key patents is for 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT. This invention focuses on compounds that exhibit 5-HT1A antagonistic activity, which are useful in treating various CNS disorders. The formula for these compounds includes R.sub.1, which can be halogen, lower alkyl or alkoxy, hydroxy, trifluoromethyl, or cyano. This patent highlights Schipper's commitment to addressing complex medical challenges through innovative chemical solutions.

Career Highlights

Jacques Schipper has been associated with Duphar International Research Bv, where he has played a pivotal role in research and development. His work at this company has allowed him to explore new avenues in drug development, particularly in the realm of CNS disorders. His dedication to research has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Throughout his career, Jacques Schipper has collaborated with esteemed colleagues, including Jan Hartog and Bartholomeus J Van Steen. These collaborations have fostered a productive environment for innovation and have contributed to the advancement of their shared goals in medical research.

Conclusion

Jacques Schipper's contributions to the field of pharmacology, particularly through his patent for 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives, demonstrate his innovative spirit and commitment to improving treatments for CNS disorders. His work continues to inspire future advancements in medical science.